metadata toggle
Contra-indications, warnings, etc
Contraindications
None
Special warnings for each target species
High level of maternal antibodies can interfere with the response to vaccination.
Maternally derived antibodies, especially those against feline panleucopenia virus, can negatively influence the immune response to vaccination.
Special precautions for use, including special precautions to be taken by the person administering the medicinal product to animals
Special precautions for use in animals
Vaccinate only healthy animals
Special precautions for the person administering the veterinary medicinal product to animals
In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician
Adverse reactions (frequency and seriousness)
Some transient post-vaccinal digestive disturbances were very commonly observed in safety studies. A slight and transient oedema which disappears spontaneously within 2 days was commonly observed during the days following vaccination in safety studies. Some transient and self-resolving post-vaccinal signs such as a slight hyperthermia and lethargy were commonly observed in safety studies.
Hypersensitivity reactions (e.g. emesis, diarrhoea, dyspnoea, allergic oedema) have been reported in very rare cases from spontaneous reports.
In case of such an allergic or anaphylactic reaction, appropriate symptomatic treatment should be administered.
As reported in the literature, after the use of any vaccine containing a Feline Calicivirus component, febrile limping syndrome reactions may occur very rarely in kittens.
Use during pregnancy, lactation or lay
Do not use during pregnancy and lactation.
Interaction with other medicinal products and other forms of interaction
Safety and/or efficacy data are available which demonstrate that this vaccine can be mixed with Leucogen. No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product except the products mentioned above. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be decided on a case by case basis.
Overdose (symptoms, emergency procedures, antidotes), if necessary
No undesirable effects have been seen after the administration of an overdose of Feligen® RCP except those indicated in section 'Adverse reactions'
Withdrawal period
Not applicable